Navigation Links
Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition

hers obtained 13 blocks of paraffin-embedded tissue samples from seven NSF/NFD patients exposed to gadolinium from the national NSF Registry of New Haven, Conn.1. An additional paraffin-embedded block containing tissue from a routine dermatopathology case served as the negative control. Researchers used a field emission scanning electron microscope equipped with electron dispersion spectroscopy to search the tissue for metals. They also were blinded as to which blocks of tissue were from NSF/NFD cases and which were from negative controls.

The study found that gadolinium was detected in four of 13 tissue specimens from patients with NSF/NFD who were exposed to the contrast agent. As expected, none of the negative controls tested positive for gadolinium.

“While clearly more research needs to be done, we are encouraged by our findings and hope that it provides an important first step in understanding the cause of this elusive disease,” said Dr. High. “Until more data becomes available, we urge patients with end-stage kidney disease and their health care providers to be aware of this potentially fatal association between gadolinium and NSF/NDF and make every effort to avoid any unnecessary, excessive dosage of this contrast agent.”

Source-Newswie
SRM
'"/>




Page: 1 2

Related medicine news :

1. Chances of Survival for Melanoma is High When Detected by Dermatologists
2. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
3. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
4. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
5. Leeches Provide Clues Regarding The Prevention Of Heart Disease
6. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
7. Reindeer Provide Valuable Insights Into Sleep Disorders
8. London Hospital Provides Specialized Care For Pregnant Women
9. CNIC To Provide Funds To Mount Sinai School
10. Clean Blades To Be Provided To Self-Harmers
11. Breastfeeding Provides Added Protection To Babies
Post Your Comments:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Within3 Expands into Mobile Applications 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 1Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 2Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 3Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 4Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 5Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 6URI research couples method targets cancerous tumors 60165 1URI research couples method targets cancerous tumors 60165 2URI research couples method targets cancerous tumors 60165 3URI research couples method targets cancerous tumors 60165 4Scientists are first to observe the global motions of an enzyme copying DNA 10548 1Scientists are first to observe the global motions of an enzyme copying DNA 10548 2Scientists are first to observe the global motions of an enzyme copying DNA 10548 3Scientists are first to observe the global motions of an enzyme copying DNA 10548 4